Plesiomonas shigelloides has been implicated as a cause of occasional gastrointestinal disease, but its role as an enteric pathogen has not been fully established, and welldocumented clinical cases are rare (5, 9, 11) . Most reports of diarrhea due to Plesiomonas spp., or of carriers, have come from tropical and subtropical regions and Japan (8, 10, 12 Stool specimens submitted for culturing were routinely inoculated onto tryptic soy agar with 5% sheep blood, Hektoen enteric agar, and MacConkey agar and into gramnegative broth. The gram-negative broth was subcultured after 18 h of incubation. Non-lactose-fermenting colonies were picked from MacConkey agar and Hektoen enteric agar (Scott/Randolph, Houston, Tex.). Oxidase activity was determined with tetramethyl-p-phenylenediamine hydrochloride reagent (Marion Scientific, Kansas City, Mo.). The API 20E system (Analytab Products, Plainview, N.Y.) was used to identify the organisms as P. shigelloides. Selective media for Aer-omonas spp. and Plesiomonas spp. were not used in these cases. As some strains fail to grow on the usual enteric media, they may be overlooked when such media are used for culturing stool specimens, leading to underreporting of these organisms. Several selective media are available for detection of Plesiomonas spp., Aeromonats spp., and related organisms, even when these organisms are present in relatively low numbers (13) .
Antimicrobial susceptibility testing (Kirby-Bauer disk diffusion) indicated that the organisms were susceptible to tetracycline, trimethoprim-sulfamethoxazole, chloramphenicol, and the aminoglycosides but were resistant to ampicillin.
Several interesting and important considerations are illustrated by our cases. Plesiomonas-associated diarrhea in normal hosts is usually a mild and self-limited disease. Patients frequently respond to symptomatic treatment, and antimicrobial therapy is rarely needed (3, 8, 10 shigelloides is recovered only rarely from the intestines of healthy subjects (2) . The disease produced by this organism seems to be much more severe in immunosuppressed patients. Therefore, in the absence of other enteric pathogens, P. shigellides isolated from immunosuppressed patients with diarrhea should be regarded as pathogenic, and the patients should be treated aggressively with antimicrobial agents (trimethoprim-sulfamethoxazole, tetracycline). This approach may also prevent the development of more serious, systemic infections, such as bacteremia, meningitis, and septic arthritis (1, 4, 6, 7) .
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